252 related articles for article (PubMed ID: 15753362)
1. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.
Nigro JM; Misra A; Zhang L; Smirnov I; Colman H; Griffin C; Ozburn N; Chen M; Pan E; Koul D; Yung WK; Feuerstein BG; Aldape KD
Cancer Res; 2005 Mar; 65(5):1678-86. PubMed ID: 15753362
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD
Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231
[TBL] [Abstract][Full Text] [Related]
3. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
[TBL] [Abstract][Full Text] [Related]
4. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.
Maher EA; Brennan C; Wen PY; Durso L; Ligon KL; Richardson A; Khatry D; Feng B; Sinha R; Louis DN; Quackenbush J; Black PM; Chin L; DePinho RA
Cancer Res; 2006 Dec; 66(23):11502-13. PubMed ID: 17114236
[TBL] [Abstract][Full Text] [Related]
5. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
Tanwar MK; Gilbert MR; Holland EC
Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
[TBL] [Abstract][Full Text] [Related]
6. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
7. Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes.
Lo KC; Rossi MR; LaDuca J; Hicks DG; Turpaz Y; Hawthorn L; Cowell JK
Genes Chromosomes Cancer; 2007 Oct; 46(10):875-94. PubMed ID: 17620294
[TBL] [Abstract][Full Text] [Related]
8. No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosis.
Boisselier B; Marie Y; El Hallani S; Kaloshi G; Iershov A; Kavsan V; Psimaras D; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
J Neurooncol; 2009 Sep; 94(2):169-72. PubMed ID: 19255724
[TBL] [Abstract][Full Text] [Related]
9. Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma.
Misra A; Pellarin M; Nigro J; Smirnov I; Moore D; Lamborn KR; Pinkel D; Albertson DG; Feuerstein BG
Clin Cancer Res; 2005 Apr; 11(8):2907-18. PubMed ID: 15837741
[TBL] [Abstract][Full Text] [Related]
10. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.
Junker N; Johansen JS; Hansen LT; Lund EL; Kristjansen PE
Cancer Sci; 2005 Mar; 96(3):183-90. PubMed ID: 15771622
[TBL] [Abstract][Full Text] [Related]
11. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
[TBL] [Abstract][Full Text] [Related]
12. Integrated high-resolution genome-wide analysis of gene dosage and gene expression in human brain tumors.
Juric D; Bredel C; Sikic BI; Bredel M
Methods Mol Biol; 2007; 377():187-202. PubMed ID: 17634618
[TBL] [Abstract][Full Text] [Related]
13. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma.
Sanai N
World Neurosurg; 2010 Jul; 74(1):4-5. PubMed ID: 21299973
[No Abstract] [Full Text] [Related]
14. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
[TBL] [Abstract][Full Text] [Related]
16. Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.
de Tayrac M; Etcheverry A; Aubry M; Saïkali S; Hamlat A; Quillien V; Le Treut A; Galibert MD; Mosser J
Genes Chromosomes Cancer; 2009 Jan; 48(1):55-68. PubMed ID: 18828157
[TBL] [Abstract][Full Text] [Related]
17. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
Horbinski C; Wang G; Wiley CA
Int J Clin Exp Pathol; 2010 Jan; 3(3):226-37. PubMed ID: 20224722
[TBL] [Abstract][Full Text] [Related]
18. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.
Godard S; Getz G; Delorenzi M; Farmer P; Kobayashi H; Desbaillets I; Nozaki M; Diserens AC; Hamou MF; Dietrich PY; Regli L; Janzer RC; Bucher P; Stupp R; de Tribolet N; Domany E; Hegi ME
Cancer Res; 2003 Oct; 63(20):6613-25. PubMed ID: 14583454
[TBL] [Abstract][Full Text] [Related]
19. Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
Necesalová E; Vranová V; Kuglík P; Cejpek P; Jarosová M; Pesáková M; Relichová J; Veselská R
Neoplasma; 2007; 54(3):212-8. PubMed ID: 17447852
[TBL] [Abstract][Full Text] [Related]
20. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets.
Fuller GN; Hess KR; Rhee CH; Yung WK; Sawaya RA; Bruner JM; Zhang W
Brain Pathol; 2002 Jan; 12(1):108-16. PubMed ID: 11771519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
